Arkolith/Insider Trading/JSPR/Form 4

TC Group, LLC

10% OwnerJasper Therapeutics, Inc. (JSPR) · full profile →Form 4 · filed Jan 31, 2023
Net Buying
Open-Market Buys
$4.7M
Open-Market Sells
$0
Net Open-Market Flow
$4.7M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 27, 2023Buy(P)3.1M$1.50$4.7M8.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-003059) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML